Living in the ‘post-antibiotic era’: could the use of probiotics be an effective strategy?
- 1 February 1997
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 3 (1) , 2-4
- https://doi.org/10.1111/j.1469-0691.1997.tb00242.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Therapeutic vaccinesJournal of Medical Microbiology, 1996
- Engineered biosynthesis of peptide antibioticsBiochemical Pharmacology, 1996
- Antimicrobial peptides: broad-spectrum antibiotics from natureClinical Microbiology & Infection, 1996
- Oligosaccharide anti-infective agentsThe Lancet, 1996
- Lipoteichoic Acid as a Target for Antimicrobial ActionMicrobial Drug Resistance, 1996
- Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial InfectionsJournal of Medicinal Chemistry, 1996
- Staphylococcal Peptidoglycan Interpeptide Bridge Biosynthesis: A Novel Antistaphylococcal Target?Microbial Drug Resistance, 1996
- The coming of age of probioticsTrends in Food Science & Technology, 1995
- Colonization resistanceAntimicrobial Agents and Chemotherapy, 1994
- The Crisis in Antibiotic ResistanceScience, 1992